The prognostic factors of chronic graft versus host disease (cGVHD) following allogeneic peripheral blood stem cell transplantation (PBSCT). Pérez-Simón JA, Encinas C, Silva F, Arcos MJ, Díez-Campelo M, Sánchez-Guijo FM, Colado E, Martín J, Vázquez L, del Cañizo C, Caballero D, San Miguel J. Biology of Blood and Marrow 14:1163-1171. FI: 3. 375 (Q2) Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response Sánchez-Guijo FM, Hernández JM, Lumbreras E, Morais P, Santamaría C, García JL, Gutiérrez NC, San Miguel JF, del Cañizo MC. Leukemia Research 33:170-173. FI: 2. 390 (Q3) Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome López Villar O, García JL, Sánchez-Guijo FM, Robledo C, Villarón EMM, López-Holgado N, Diez-Campelo M, Barbado V, Pérez-Simón JA, Hernández-Rivas JM, San Miguel JF, del Cañizo MC. Leukemia 23:664-672. FI: 8. 634 (Q1) Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared to those from normal donors Garayoa M, García JL, Santamaría C, García-Gómez A, Blanco JF, Pandiella A, Hernández JM, Sánchez-Guijo FM, del Cañizo MC, Gutiérrez NC, San Miguel JF. Leukemia 23:1515-1527. FI: 8. 634 (Q1) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy Pérez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, López T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA. Transfusion 49:1901-1910. FI: 3. 475 (Q2) Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura Pérez-Simón JA, Tabera S, Sarasquete ME, Díez-Campelo M, Canchado J, Sánchez-Abarca LI, Blanco B, Alberca I, Herrero-Sánchez C, Cañizo C, San Miguel JF. Cytotherapy 94:975-983. FI: 5. 978 (Q1) Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population Blanco B, Pérez-Simón JA, Sánchez-Abarca LI, Caballero-Velázquez T, Gutiérrez-Cossío S, Hernández-Campo P, Díez-Campelo M, Herrero-Sánchez C, Rodríguez-Serrano C, Santamaría C, Sánchez-Guijo FM, Del Cañizo C, San Miguel JF. Haematologica 11:1041-1051.FI: 3. 471 (Q2) Prospective comparative analysis of monocytes and CD133+ cells in a murine model of hindlimb ischemia López-Holgado N, Alberca M, Sánchez-Guijo FM, Villarón EMM, Rivas JV, López-Novoa JM, Briñón JG, Arévalo MA, Oterino E, Santamaría C, San Miguel JF, del Cañizo MC. 336(3):501-507 FI: 2. 308 (Q3) Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone using a novel isolation method with those obtained from iliac crest aspiration from the same subjects Sánchez-Guijo FM, Blanco JF, Cruz G, Muntión S, Gómez M, Carrancio S, López-Villar O, Barbado MV, Sánchez-Abarca LI, Blanco B, Briñón JG, del Cañizo MC. Cell and Tissue Research 336(3):501-507. FI: 2. 308 (Q3) Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease Villanueva FN, Pérez-Simón JA, Silva F, Caballero-Velázquez T, Sánchez-Guijo FM, Cañizo C, Vázquez L, Caballero D, San Miguel JF Biology of Blood and Marrow 15:1331-1336. FI: 3. 375 (Q2)
|
